Quick Answer
BioScience Health Innovations, Inc. reported Gross Profit of $3.24 million for fiscal year 2025.
BioScience Health Innovations, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $3.24M | +147.6% |
| 2024 | $1.31M | +170.2% |
| 2023 | $484.4K | +712.2% |
| 2022 | $59.6K | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $698.2K | +64.4% | -35.0% |
| June 30, 2025 | $1.07M | +246.2% | +19.9% |
| March 31, 2025 | $896.1K | +281.7% | +111.0% |
| September 30, 2024 | $424.7K | +164.9% | +36.8% |
| June 30, 2024 | $310.4K | +417.6% | +32.2% |
| March 31, 2024 | $234.8K | +750.9% | +46.4% |
| September 30, 2023 | $160.3K | +877.9% | +167.4% |
| June 30, 2023 | $60.0K | +748.5% | +117.3% |
- BioScience Health Innovations, Inc. showed an increase of +147.6% in Gross Profit compared to the prior fiscal year.
- Over the 2022–2025 period, BioScience Health Innovations, Inc.’s gross profit has grown by 5333.4% (from $59.6 thousand to $3.24 million).
- The most recent figure is from BioScience Health Innovations, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: